摘要:日本学者Yamada等首先应用预激疗法治疗难治、复发性急性髓系白血病(AML),疗效显著,国内也有相应报道,但主要应用CAG方案,即小剂量阿糖胞苷(Ara-C)、阿克拉霉素(ACR)联合G-CSF。我们用高三尖杉酯碱(HHT)代替ACR组成CHG预激方案治疗难治、复发性AML,并对比观察了CHG和CAG方案的疗效,现将结果报告如下。
注:因版权方要求,不能公开全文,如需全文,请咨询杂志社
热门期刊服务
川化 测绘 Cell Research Nuclear Science and Techniques Neural Regeneration Research Chinese Journal of Cancer Research Plasma Science and Technology High Technology Letters Tsinghua Science and Technology Journal of Iron and Steel Research Journal of Beijing Institute of Technology Journal of Harbin Institute of Technology